Intracellular CHO Cell Metabolite Profiling Reveals Steady‐State Dependent Metabolic Fingerprints in Perfusion Culture

Perfusion cell culture processes allow the steady‐state culture of mammalian cells at high viable cell density, which is beneficial for overall product yields and homogeneity of product quality in the manufacturing of therapeutic proteins. In this study, the extent of metabolic steady state and the change of the metabolite profile between different steady states of an industrial Chinese hamster ovary (CHO) cell line producing a monoclonal antibody (mAb) was investigated in stirred tank perfusion bioreactors. Matrix‐assisted laser desorption/ionization time of flight mass spectrometry (MALDI‐TOF‐MS) of daily cell extracts revealed more than a hundred peaks, among which 76 metabolites were identified by tandem MS (MS/MS) and high resolution Fourier transform ion cyclotron resonance (FT‐ICR) MS. Nucleotide ratios (Uridine (U)‐ratio, nucleotide triphosphate (NTP)‐ratio and energy charge (EC)) and multivariate analysis of all features indicated a consistent metabolite profile for a stable culture performed at 40 × 106 cells/mL over 26 days of culture. Conversely, the reactor was operated continuously so as to reach three distinct steady states one after the other at 20, 60, and 40 × 106 cells/mL. In each case, a stable metabolite profile was achieved after an initial transient phase of approximately three days at constant cell density when varying between these set points. Clear clustering according to cell density was observed by principal component analysis, indicating steady‐state dependent metabolite profiles. In particular, varying levels of nucleotides, nucleotide sugar, and lipid precursors explained most of the variance between the different cell density set points. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 33:879–890, 2017

[1]  R. Goodacre,et al.  Metabolite profiling of CHO cells: Molecular reflections of bioprocessing effectiveness. , 2015, Biotechnology journal.

[2]  R. Goodacre,et al.  Metabolite profiling of recombinant CHO cells: designing tailored feeding regimes that enhance recombinant antibody production. , 2011, Biotechnology and bioengineering.

[3]  Yao-ming Huang,et al.  Perfusion seed cultures improve biopharmaceutical fed‐batch production capacity and product quality , 2014, Biotechnology progress.

[4]  Massimo Morbidelli,et al.  Characterization and comparison of ATF and TFF in stirred bioreactors for continuous mammalian cell culture processes , 2016 .

[5]  Dong-Yup Lee,et al.  Metabolomics-driven approach for the improvement of Chinese hamster ovary cell growth: overexpression of malate dehydrogenase II. , 2010, Journal of biotechnology.

[6]  I. Gout,et al.  Coenzyme A biosynthetic machinery in mammalian cells. , 2014, Biochemical Society transactions.

[7]  Konstantin B Konstantinov,et al.  White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium. , 2015, Journal of pharmaceutical sciences.

[8]  Rashmi Kshirsagar,et al.  Concentrated fed-batch cell culture increases manufacturing capacity without additional volumetric capacity. , 2016, Journal of biotechnology.

[9]  Thomas Ryll,et al.  Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipment , 2010, Biotechnology progress.

[10]  T. Traut,et al.  Physiological concentrations of purines and pyrimidines , 1994, Molecular and Cellular Biochemistry.

[11]  M. Butler,et al.  Effect of temperature on nucleotide pools and monoclonal antibody production in a mouse hybridoma , 1994, Biotechnology and bioengineering.

[12]  Thomas K. Villiger,et al.  Evaluating the impact of cell culture process parameters on monoclonal antibody N-glycosylation. , 2014, Journal of biotechnology.

[13]  Konstantin Konstantinov,et al.  End-to-end integrated fully continuous production of recombinant monoclonal antibodies. , 2015, Journal of biotechnology.

[14]  I. Gout,et al.  EDC4 interacts with and regulates the dephospho‐CoA kinase activity of CoA synthase , 2012, FEBS letters.

[15]  T. Ryll,et al.  Improved ion-pair high-performance liquid chromatographic method for the quantification of a wide variety of nucleotides and sugar-nucleotides in animal cells. , 1991, Journal of chromatography.

[16]  Dong-Yup Lee,et al.  Metabolomics-based identification of apoptosis-inducing metabolites in recombinant fed-batch CHO culture media. , 2011, Journal of biotechnology.

[17]  Nathan E Lewis,et al.  The emerging CHO systems biology era: harnessing the 'omics revolution for biotechnology. , 2013, Current opinion in biotechnology.

[18]  M. Klapa,et al.  Metabolic profiling reveals that time related physiological changes in mammalian cell perfusion cultures are bioreactor scale independent. , 2013, Metabolic engineering.

[19]  Sen Xu,et al.  High-density mammalian cell cultures in stirred-tank bioreactor without external pH control. , 2016, Journal of biotechnology.

[20]  Natarajan Vijayasankaran,et al.  Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process , 2011, Biotechnology and bioengineering.

[21]  J. Goergen,et al.  Intracellular nucleotide and nucleotide sugar contents of cultured CHO cells determined by a fast, sensitive, and high-resolution ion-pair RP-HPLC. , 2006, Analytical biochemistry.

[22]  Dong-Yup Lee,et al.  LC‐MS‐based metabolic characterization of high monoclonal antibody‐producing Chinese hamster ovary cells , 2012, Biotechnology and bioengineering.

[23]  D. E. Atkinson.  Regulation of enzyme function. , 1969, Annual review of microbiology.

[24]  Charles L. Cooney,et al.  White Paper on Continuous Bioprocessing , 2014 .

[25]  T. Ryll,et al.  Intracellular ribonucleotide pools as a tool for monitoring the physiological state of in vitro cultivated mammalian cells during production processes , 1992, Biotechnology and bioengineering.

[26]  Nicholas E. Timmins,et al.  Metabolite profiling of CHO cells with different growth characteristics , 2012, Biotechnology and bioengineering.

[27]  F. Wurm.  Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[28]  Massimo Morbidelli,et al.  High‐throughput nucleoside phosphate monitoring in mammalian cell fed‐batch cultivation using quantitative matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry , 2015, Biotechnology journal.

[29]  Niki S. C. Wong,et al.  Combined in silico modeling and metabolomics analysis to characterize fed‐batch CHO cell culture , 2012, Biotechnology and bioengineering.

[30]  D. Berkich,et al.  Rate-limiting step and control of coenzyme A synthesis in cardiac muscle. , 1982, The Journal of biological chemistry.

[31]  Massimo Morbidelli,et al.  Microarray-based MALDI-TOF mass spectrometry enables monitoring of monoclonal antibody production in batch and perfusion cell cultures. , 2016, Methods.

[32]  K. Jefimovs,et al.  Self-aliquoting microarray plates for accurate quantitative matrix-assisted laser desorption/ionization mass spectrometry. , 2013, Analytical chemistry.

[33]  Chetan T Goudar,et al.  Metabolomics for high-resolution monitoring of the cellular physiological state in cell culture engineering. , 2010, Metabolic engineering.

[34]  Characterization of intrinsic variability in time‐series metabolomic data of cultured mammalian cells , 2015, Biotechnology and bioengineering.

[35]  Michael C. Borys,et al.  The use of ‘Omics technology to rationally improve industrial mammalian cell line performance , 2016, Biotechnology and bioengineering.

[36]  T. Traut.  Allosteric Regulatory Enzymes , 2007 .